Alnara Pharmaceuticals

About:

Alnara Pharmaceuticals develops and commercializes orally-delivered protein therapeutics for the treatment of metabolic diseases.

Website: http://www.alnara.com

Top Investors: Third Rock Ventures, MPM Capital, Frazier Healthcare Partners, Longwood Fund, Bessemer Venture Partners

Description:

Alnara Pharmaceuticals, Inc. is dedicated to developing novel protein therapeutics for the treatment of metabolic diseases. The company's innovative approach focuses on designing effective protein therapies that can be orally delivered directly to the gastrointestinal tract without being absorbed into the bloodstream.